ARTICLE | Clinical News
GAL-021: Clinical trial data
September 22, 2014 7:00 AM UTC
A double-blind, placebo-controlled, crossover, proof-of-concept (POC) trial in 12 healthy volunteers showed that IV GAL-021 protected against alfentanil-induced respiratory depression without affectin...